Rodinah Chalwe, former Ambassador at Latkings Outreach Program, funded by Positive Action Girls & Women Fund

Positive Action (Global)’s mission is to be a transformational partner that champions people and communities to end AIDS. Our vision is healthy communities in a world free of AIDS.

We do this through putting people and communities first, strengthening capacity and collaborating strategically.

Originally set up as part of GSK’s Global Health Programmes, Positive Action was created in 1992 as the first pharmaceutical company community-grant giving programme to support communities affected by HIV and AIDS.

Positive Action exists to further the ViiV Healthcare mission of ensuring no person living with HIV is left behind, by working directly with the communities most affected by HIV.

Click here to download our high-level strategy, or here for our logic framework which demonstrates how we will achieve our overall strategy.

Our approach is twofold:

Community Strategic Initiatives (CSI) Funding

Innovator grants (up to GBP 50,000 per year, over two years)

  • First-time investments in novel ideas or in new contexts
  • 1-2-year pilot/seed community-led projects

Momentum grants (up to GBP 100,000 per year, over three years)

  • Advancing existing, evidence-based projects to enable sustainable scale-up with other funding/implementing partners
  • Larger financial commitments with expected co-investment with other funding bodies
  • Multiyear (3+), staged-funding programmes

Please refer to the CSI page for further information around specific requests for proposals.

Breakthrough and Strategic Partnership Investments

  • Strategic grants (longer term investments)
  • Supporting stakeholders to scale up their HIV efforts to achieve national HIV related targets
  • Participating in multilateral long-term partnerships
  • Investing in subject-specific specialised funding modalities

Please see the Breakthrough & Strategic Partnerships page for more information.

For any enquiries relating to the Positive Action strategy 2020 - 2030 or the funding rounds please email: WW.PositiveAction@viivhealthcare.com

For any enquiries relating to pre-2020 grants, please email: positiveaction.grants@viivhealthcare.com


AMPLIFY IMPACT enables the accompaniment, collaboration and learning needed to achieve the goals of the ViiV Healthcare Positive Action strategy, “Healthy Communities in a world free of AIDS”. The approach is based on a respect for human rights and is conscious of power and power relations that lie at the heart of our work. Our starting point is to begin from a clear purpose, intent and alignment to strategy.

AMPLIFY IMPACT consists of a series of support options designed to facilitate joined-up impact, ongoing learning and improvement and builds on and replaces earlier, more limited offers of Technical Assistance.

We believe that non-financial assistance should enable partners to be fit-for-purpose and aligned to our strategy and this will require a degree of flexibility and responsiveness within Positive Action.


Accompaniment: Technical assistance is available to support grantees with an additional fixed budget allocation (up to 10% of total grant size) to procure required technical assistance for institutional strengthening areas. This is only available to grantees in Innovator and Momentum grants and is self-managed by the grantee and reported on, in line with clear pre-defined requirements and criteria. This has to be applied for during the grant application process. This is clearly marked in the application form.

  • Grantees will be able to identify consultants
  • Technical assistance is focused on the areas of institutional strengthening (Organisational development, Governance, Systems, etc.)
  • Capacity building is available in some thematic areas directly related to the project scope and procured by the grantee

For information on this support category and to find out if you are eligible to apply please email: AMPLIFY.IMPACT@viivhealthcare.com using the subject heading: TA Support Application

Skills Connector: Ability to access advice and short-term, long-distance, specialised support from GSK/ViiV Employees.

Skills Connector focuses on providing a package of support from three hours to ten days (per calendar year) to existing Positive Action grantees. The support available focuses on the following broad areas:

  • Business Development and Change Management
  • Communications (media, messaging and publicity)
  • Data Management and Knowledge Transfer (enhancing data value and distribution)
  • Information Technology (IT) (networking and infrastructure)
  • Representation and Influence (public speaking, effective representation)
  • Sales and/or Marketing (promoting services, securing clients, raising money)

Please note that the Skills connector offer is available to all existing Positive Action grantees.

For information on this support category or to apply please complete the application form  here and email it to:  AMPLIFY.IMPACT@viivhealthcare.com using the subject heading:  Skills Connector Application

Collaboration: Focused and tailor-made grant management support from the Positive Action team and through the Positive Action Allies programme.

  • The grant manager/Ally collaborates with the grantee to ensure strong grant management and overall performance
  • Opportunity to connect with other grantees through relevant Linking-and-Learning events and spaces

For information on this support category and to find out if you are eligible to apply please email: AMPLIFY.IMPACT@viivhealthcare.com using the subject heading: Collaboration Application

Learning: Linking partners and grantees to lessons, expertise and insights from other grantmaking streams and sharing results across the portfolio (e.g. paediatric AIDS, harm reduction, HIV related stigma, etc.)

  • Thematic Linking-and-Learning spaces (online) and events (online/in person) act as points for learning and exchange, and spaces for initiating new strategic relationships and partnerships amongst grantees
  • Using data and learning to inform and shape policy positions and advocacy positions

For information on this support category and to find out if you are eligible to apply please email: AMPLIFY.IMPACT@viivhealthcare.com using the subject heading: Learning Application

Breakthrough and Strategic Partnerships

Strategic partnerships are informed and shaped by developing and co-creating shared objectives towards a common outcome aligned to the Positive Action strategy and are therefore essential in supporting Positive Action deliver against its 2020 – 2030 strategy.

Priority themes identified for Positive Action (2021-23) are:

  1. Ending paediatric AIDS.
  2. Reducing new HIV infections in people who use drugs to zero in targeted settings.
  3. Tackling HIV related stigma.

Funding is available under the Strategic Partnerships funding stream for the first two priority areas in 2021.

The Breakthrough Paediatric partnership sits within Strategic Partnerships.

Information on the ViiV Healthcare Positive Action Paediatric Breakthrough Partnership

The Breakthrough partners, working with government and community, aim to locate, link, treat and retain mothers and children at risk or living with HIV.

The purpose of the Breakthrough Partnership is to:

  • End paediatric AIDS in priority locations by implementing a high-quality package of sustainable and replicable interventions that is informed by the UNICEF Paediatric Service Delivery Framework
  • Develop and amplify evidence that a collaborative approach between stakeholders (government, clinic and community) works, as well as advocate for governments and other stakeholders to adopt a similarly collaborative approach.
The Partnership involves:
  • Year 1 (present – July 2021): partnership implementation in select locations in Mozambique, Uganda and Nigeria
  • Year 2 (August 2021 – July 2022): continued implementation and expansion in Year 1 countries; review and feasibility assessment of additional countries
  • Year 3 (August 2022 – July 2023): further implementation, evaluation and recommendations for scaling up and knowledge sharing
Click here to view the paediatric Breakthrough grant infographic.
The Breakthrough Partnership works with implementation science researchers at UVRI-IAVI to understand the impact of our work. UVRI-IAVI’s research project seeks to understand how well our Partnership works together, and if working together yields greater results than if each partner had worked on their own.


Positive Action Challenges seek to find innovative solutions to a particular issue or challenge.

We are pleased to announce the selected award recipients of the most recent Challenge we ran in partnership with IAS and INPUD. This Challenge invited applications that focus specifically on community or peer-led initiatives that aim to provide comprehensive, innovative and accessible harm reduction services at the community level for people who inject drugs.

The following organisations were selected due to meeting some or all of the following criteria:

  • Community or peer-led.
  • Meaningfully engaging and involving the community of people who inject drugs in the design and delivery of their initiative.
  • Promoting non-stigmatising, inclusive and comprehensive care for people who use drugs.
  • Describing how harm reduction services can be integrated into existing community or local public health HIV support services.
  • Being able to demonstrate how the initiative drives increased and sustained access to HIV services and support through addressing current barriers.
  • Demonstrating how the project can be sustained beyond the award.

Seed award recipients to pilot a new idea:

Zambian Equality Forum Limited
Reducing HIV infection and harm reduction among LGBTI and MSM who inject drugs

Key objectives of the project include identifying and addressing key determinants of risk behaviours among LGBTI and MSM who inject drugs, and expanding tailored, evidence-informed and community led behaviour change interventions.

Find out more here

Teens Link Uganda
Stepping up harm reduction services for people who inject drugs in Wakiso (PWID), Uganda

The project aim is to improve 90-90-90 health outcomes for PWID by using combination prevention approaches such as accelerating access to essential harm reduction services, and addressing human rights, social and structural barriers to access.

Find out more here

Recovering Nepal 
Provisioning for gender friendly harm reduction services to women who use drugs

Project objectives include identifying areas of concentration of women who inject drugs and their behavioural patterns through situational assessment and enabling the target group to access harm reduction services.

Find out more here


Grand award recipient to scale a proven project:

Andrey Rylkov Foundation for Health and Social Justice
The provision of harm reduction services to people who inject drugs on the streets of Moscow

Project objectives include the continuation of outreach work on the streets of Moscow providing integrated services on HIV, HCV, overdose prevention, mental health, legal aid and access to health and rights case management.

Find out more here

Hear from Stephen Rea, Head of ViiV Communications and Government Affairs, and our sponsors, IAS and INPUD at AIDS2020: Virtual below:

The Review Panel


Other members of the review panel

Syda Productions/Shutterstock.com

Syda Productions/Shutterstock.com

HIV infections among people who inject drugs are rising. People who inject drugs and their sexual partners accounted for around one fifth of all people newly infected with HIV (outside of sub-Saharan Africa) in 2018. In two regions of the world—eastern Europe and central Asia and the Middle East and North Africa—people who inject drugs accounted for more than one third of new infections in 2018. Viral hepatitis and tuberculosis rates among people who use drugs are also high in many parts of the world. These preventable and treatable diseases, combined with overdose deaths, which are also preventable, are claiming hundreds of thousands of lives each year. In many countries across the globe, injecting drug use is not often acknowledged, and a public health response therefore not implemented.

Harm reduction is rooted in a commitment to addressing discrimination and ensuring that nobody is excluded from the health and social services they may need because of their drug use, their race, their gender, their gender identity, their sexual orientation, their choice of work, or their economic status. The meaningful involvement of people who use drugs in designing, implementing and evaluating programmes and policies that serve them is central to harm reduction.

Comprehensive harm reduction services — including needle–syringe programmes, opioid substitution therapy, drug dependence treatment, overdose prevention and testing and treatment for HIV, tuberculosis and hepatitis B and C— reduce the incidence of blood-borne infections, overdose deaths and other harms.

Community Strategic Initiatives seek to enable people and communities to improve the quality of life of people living with and those most at risk of HIV.

For this Positive Action strategy funding is provided in the form of:

Innovator grants (up to GBP 50,000 per year, over two years)

  • First-time investments in novel ideas or in new contexts
  • 1-2-year pilot/seed community-led projects

Momentum grants (up to GBP 100,000 per year, over three years)

  • Advancing existing, evidence-based projects to enable sustainable scale-up with other funding/implementing partners
  • Larger financial commitments with expected co-investment with other funding bodies
  • Multiyear (3+), staged-funding programmes

Innovator Grants

The Positive Action 2021 Round 1 funding for Innovator Grants focusing on Community Based Harm Reduction Services is now closed.

Final decision, verification and contracting is ongoing. All recommended applicants have now been informed of the outcome.

Momentum Grants

The Positive Action 2021 Round 2 funding for Momentum Grants focusing on ending paediatric AIDS through improving retention in HIV care for children is now closed.

All applicants have now been informed of the outcome of their application. Verification and contracting for recommended applicants will happen from July 2021 onwards. These dates are provided as a guide.

Community Emergency Response Fund

ViiV Healthcare’s COVID19 Community Emergency Response Fund supported community-based organisations in their work to address the specific challenges that have arisen for people living with HIV or affected by HIV as a result of the COVID-19 pandemic.

Proposals were received in the following thematic areas:

  • Support for ongoing access to critical HIV prevention, care and treatment services (adherence support interventions, psychosocial support, strengthening access to ARVs, strategies for hard to reach populations, etc.)
  • Capacity building to support the transition of service delivery from face to face service delivery to home or digital services etc.
  • Short term payments for critical community staff who are responding to COVID19 challenges (salaries, airtime, data, transport costs etc.)
  • Community monitoring and community feedback mechanisms on impact of COVID19 HIV services and support.

All recommended applicants have now been informed of the outcome. If you have not heard from the Positive Action team you can assume that your application has been unsuccessful.